[Special Stock] Intromedic Hits Upper Limit on News of Global Distribution Contract for COVID-19 Diagnostic Kits
[Asia Economy Reporter Park Jihwan] Intromedic recorded a limit-up following the news of signing a global distribution contract for a portable specimen diagnostic kit that diagnoses COVID-19 within 20 minutes.
As of 2:10 PM on the 12th, Intromedic is trading at 3,800 KRW, up 875 KRW (29.91%) from the previous day.
On this day, Intromedic announced that it had signed a global distribution contract with gene analysis specialist company IoneBio for the diagnostic kit ‘Novel-Cov-19 LAMP PCR Kit,’ which can diagnose COVID-19 infection within 20 minutes.
IoneBio developed the viral gene testing reagent ‘Novel-Cov-19 LAMP PCR Kit’ and completed clinical testing.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
This specimen kit is a gene testing reagent that detects the COVID-19 virus gene using an isothermal amplification method based on real-time reverse transcription polymerase chain reaction. While utilizing the principle of PCR (gene amplification) currently in use, it incorporates the principle of isothermal amplification, reducing the PCR reaction time and thus shortening the final reporting time.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
